Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study.
Renato de OliveiraBárbara Gomes MayaMariana Bittencourt Silva NogueiraGabriel Seixas ConceiçãoCaio P BarbosaCaio Parente BarbosaPublished in: Einstein (Sao Paulo, Brazil) (2021)
The use of oral progestins, in spite of requiring longer treatment time, is effective in relation to the protocol with gonadotropin-releasing hormone antagonist, and offers greater comfort at a lower cost in breast cancer patients with negative progesterone receptors, submitted to cancer fertility preservation.